SALT LAKE CITY, Oct. 04, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) of advanced ceramic materials for medical and technical applications, announced today it has been awarded four new international patents for antibacterial biomedical implants.

Awarded by the countries of Canada, Australia (two patent awards), and Japan, these patents enhance SINTX’s portfolio of intellectual property. Silicon Nitride, one of the premium bioceramics offered by SINTX, has been shown previously to exhibit the bacteriostatic benefits sought after in medical implants. These patent awards and the protection they provide enable SINTX to offer even greater value to medical device partners operating within the protected geographies.

“At SINTX, we value our intellectual property, and these awards strengthen our IP portfolio,” said Dr. Ryan Bock, Vice President of Research and Development, SINTX Technologies. “The topic of antibacterial protection for medical implants is of interest across all surgical areas because bacteria and infection continue to represent some of the most significant issues within healthcare. SINTX has already received interest in our material from med-tech companies looking for a way to reduce bacteria issues associated with their implants.”

Evolving from a spine company, SINTX Technologies has expanded and diversified significantly through entering new markets and acquisition. The recent acquisition of Technology Assessment & Transfer (TA&T) expanded the Company’s product portfolio into other ceramic materials such as zirconia and alumina, both for medical and industrial applications. Today, SINTX is dedicated to the manufacturing, research, and development of advanced materials science-based solutions to improve quality of life.

For more information, please visit https://sintx.com/.

SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past two years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing facilities in Utah and Maryland.

Forward-Looking Statements for SINTX Technologies, Inc.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences include, among other things: incorporation of silicon nitride into medical implants or other products may not result in bacteriostatic benefits or prove to be commercially viable; the FDA may not clear any products for commercialization; the industry may not accept the new products or may turn to products they deem more effective or less expensive; patients may not realize the expected benefits of our products; volatility in the price of SINTX’s common stock; the uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of our products once commercialized; SINTX’s ability to raise additional funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations, and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 25, 2022, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.

Business or Media Inquiries for SINTX:

SINTX Technologies 801.839.3502 IR@sintx.com

Actually, The Wall Street Journal's Nick Timiraos did: The Fed may be trying to figure out whether to slow the pace of rate increases.

Few high-profile money managers have a nose for making money quite like Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett. In the 57 years since taking the reins, the Oracle of Omaha, as he's come to be known, has led his company's Class A shares (BRK.A) to a jaw-dropping average annual return of 20.1%. The Oracle of Omaha believes diversification is "protection against ignorance."

We’re facing a storm of volatility, as a series of short rallies have added a layer of confusion on top of the year’s bearish trends. The combination of headwinds – high inflation and rising interest rates, a probable recession around the corner – are threatening a stagflation that hasn’t been seen since the 1970s. Writing on current conditions from Morgan Stanley, chief US equity strategist Mike Wilson lays out reasons for investor patience, in his forecast of where the main indexes are likely

The danger is that illiquidity and volatility in stocks and bonds will feed off each other, made worse by foreign central banks forced to sell Treasuries to defend their currencies against a rising dollar.

There's no way to know for sure which stocks Buffett is buying. But these two are probably at the top of his list.

U.S. stocks end sharply higher Friday as investors weighed a story from the Wall Street Journal and comments from Federal Reserve officials suggesting that the central bank might shift to smaller interest-rate rises after its November meeting.

Wood's Ark Innovation ETF has plunged 64% so far this year, and is down 78% from its February 2021 peak.

NEW YORK (Reuters) -The banks providing $13 billion in financing for Tesla CEO Elon Musk's acquisition of Twitter Inc have abandoned plans to sell the debt to investors because of uncertainty around the social media company's fortunes and losses, people familiar with the matter said. The banks are not planning to syndicate the debt as is typical with such acquisitions, and are instead planning to keep it on their balance sheets until there is more investor appetite, the sources said. The banks, which include Morgan Stanley, Bank of America, and Barclays Plc, declined to comment.

Medical Properties (MPW) closed the most recent trading day at $10.99, moving -0.09% from the previous trading session.

One company that could continue to experience challenging times in the near term is Shopify (NYSE: SHOP). The possibility of a recession will affect the company in several ways. The company's revenue is somewhat linked to its gross merchandise volume (GMV), or the total value of transactions conducted on its platform.

Tesla’s stock has been in a tailspin. But if the electric-vehicle maker is able to navigate a few bumpy months, it will be a signal that it’s headed in the right direction.

Plug Power (PLUG) closed the most recent trading day at $16.49, moving +0.98% from the previous trading session.

Typically, a lot of effort is required to make the money needed initially to generate passive income. Investing in stocks that pay high dividend yields is one of the easiest ways to make money without working for it. Here are three high-yield dividend stocks that could be passive-income machines.

Yahoo Finance's Seana Smith breaks down the top tickers for the week.

With the market volatility continuing, these three dividend stocks are worth putting on your watch list.

These bargain-priced growth stocks are ripe for the picking with the Nasdaq Composite plunging by as much as 38%.

Verizon Communications Inc. shares sunk to an 11-year low Friday after the cell phone carrier reported a 23% drop in third-quarter profits as wireless subscriber growth slowed. The New York-based company also said it’s launching a new cost-savings program to improve operating efficiencies and mitigate inflation impacts. Verizon (NYSE: VZ) said third-quarter net income fell 23% to $5 billion, or $1.17 per share, from $6.6 billion, or $1.55 per share, a year ago.

401(k) contribution limits for 2023 follow a big bump to tax brackets and the size of the standard deduction

Millions of Americans can save more in retirement accounts next year, after inflation adjustments made by the Internal Revenue Service.

When we reviewed shares of Verizon Communications back on August 31 when we wrote, "Avoid the long side of VZ as the short and long-term charts are bearish." On Friday shares of VZ sank to a new 52-week low on the heels of missing analyst estimates of Q3 subscribers. The On-Balance-Volume (OBV) has made new lows for the move down as well and confirms the observation that sellers of VZ have been more aggressive than buyers.